Gaye, Elisabeth <br/><br/>
Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  07 2019 
 - 1-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2019.04.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anaplastic Lymphoma Kinase--antagonists & inhibitors<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Crizotinib--therapeutic use<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Meningeal Carcinomatosis--drug therapy<br/>Middle Aged<br/>Organophosphorus Compounds--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Survival Analysis